Research News

---

Topic: Chemotherapy (view all topics)

Tags for topic Chemotherapy:

• Abraxane (chemical name: paclitaxel)
• Adjuvant
• Adriamycin (chemical name: doxorubicin)
• Anthracyclines
• carboplatin (brand name: Paraplatin)
• Cytoxan (chemical name: cyclophosphamide)
• daunorubicin (brand names: Cerubidine, DaunoXome)
• Dose Dense
• Doxil (chemical name: doxorubicin)
• Ellence (chemical name: epirubicin)
• fluorouracil (also called 5-fluorouracil or 5-FU; brand name: Adrucil)
• Halaven (chemical name: eribulin)
• Ixempra (chemical name: ixabepilone)
• mitoxantrone (brand name: Novantrone)
• Navelbine (chemical name: vinorelbine)
• Neoadjuvant
• Standard
• Taxanes
• Taxol (chemical name: paclitaxel)
• Taxotere (chemical name: docetaxel)
• Xeloda (chemical name: capecitabine)

View articles by month and year

• Xeloda Less Effective Than Standard Chemo for Older Women

  Published on June 2, 2008 at 12:00 am

  • Tags: Xeloda (chemical name: capecitabine) and Standard

  Xeloda (chemcial name capecitabine) isn't as good as traditional IV chemotherapy at reducing the risk of breast cancer coming back in women older than 65 diagnosed with early-stage or locally advanced breast cancer (cancer that hadn't metastasized).

• Taxol Added to Chemo Combination Improved Survival of Women Diagnosed with Early-Stage Breast Cancer

  Published on May 30, 2008 at 12:00 am

  • Tags: Cytoxan (chemical name: cyclophosphamide), Ellence (chemical name: epirubicin), fluorouracil (also called 5-fluorouracil or 5-FU; brand name: Adrucil), Taxol (chemical name: paclitaxel), and Standard

  After surgery to treat early-stage breast cancer, women who got Taxol after the FEC (fluorouracil, Ellence, Cytoxan) chemotherapy combination were more likely to be alive and cancer-free 5 years after diagnosis than women who got only FEC.

• Zometa May Lower Risk of Breast Cancer Spreading to Bones

  Published on May 16, 2008 at 12:00 am

  • Tags: Adjuvant

  Research suggests that Zometa, a bone-strengthening medicine, may slow the spread of breast cancer to bones.

• Taxol Weekly Better Than Every Three Weeks for Breast Cancer

  Published on April 17, 2008 at 12:00 am

  • Tags: Adriamycin (chemical name: doxorubicin), Cytoxan (chemical name: cyclophosphamide), Taxol (chemical name: paclitaxel), Taxotere (chemical name: docetaxel), Dose Dense, and Standard

  Getting Taxol (chemical name: placlitaxel) every week seems to have more benefits than getting it every 3 weeks or getting Taxotere (chemical name: docetaxel) on either schedule.

• “Chemobrain” May Be Due to Stress

  Published on April 17, 2008 at 12:00 am

  • Tags: Standard

  Two small studies suggest that "chemobrain" is more likely because of stress and the emotional toll of a breast cancer diagnosis rather than chemotherapy.

• Developing Anemia During Chemo Ups Risk of Recurrence

  Published on April 1, 2008 at 12:00 am

  • Tags: Standard

  Developing anemia during chemotherapy to treat early-stage breast cancer seems to affect the risk of the cancer coming back.

• Herceptin with Dose-Dense Chemo Reduces Risk of Heart Problems

  Published on March 7, 2008 at 12:00 am

  • Tags: Dose Dense and Herceptin

  A small study has found that when Herceptin (chemical name: trastuzumab) was given in combination with dose-dense chemotherapy, the risk of heart problems from Herceptin was lower than when Herceptin was given with a routine schedule of chemotherapy.

• Chemotherapy After Surgery Reduces Recurrence Risk of Hormone-Receptor-Negative Breast Cancer

  Published on January 4, 2008 at 12:00 am

  • Tags: Standard

  Chemotherapy after surgery significantly reduces the risk of hormone-receptor-negative breast cancer coming back and increases survival, according to a review of previous research.

• Tamoxifen and Chemo Reduce Risk of New, Second Cancer

  Published on December 25, 2007 at 12:00 am

  • Tags: Standard, Tamoxifen, and After surgery (also called "adjuvant")

  Tamoxifen and chemotherapy reduce the risk of developing a new, second breast cancer in the other breast.

• Circulating Tumor Cell Levels Show Treatment Is Working

  Published on December 18, 2007 at 12:00 am

  • Tags: Standard

  Measuring circulating tumor cells in the bloodstream may offer doctors a way to tell is chemotherapy is working against metastatic breast cancer.